/
Oncology
Head Neck Cancer
10
Pipeline Programs↗
13
Active Trials↗
14
Companies Involved↗
Head Neck Cancer is an early-stage landscape with 10 programs across 14 companies. The most active players are CD (Suzhou) Biopharma Co., Ltd., Second Life Therapeutics.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical1
Phase 28
Phase 3
No programs
Approved
No programs
Analysis
Modality Breakdown
9programs
Monoclonal antibody556%
Small molecule444%
Modality classified for 100% of 10 pipeline programs.
Analysis
Trial Status
28
clinical trials
Completed11 · 39%
Recruiting6 · 21%
Not yet recruiting4 · 14%
Active, not recruiting3 · 11%
Unknown status2 · 7%
Terminated2 · 7%
Clinical Trials
Trial Activity
28 trials
Radiotherapy With Tislelizumab in Patients With Recurrent Head & Neck Cancer
Recruiting·TTianjin Medical University Cancer Institute and Hospital·Phase 2·NCT05595590·20 enrolled
A Prospective, Single-Arm, Phase II Clinical Study of Nimotuzumab Combined With Radiotherapy for Elderly Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Not yet recruiting·—·Phase 2·NCT07821242·46 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)